Reference desk / Entry
Copper tripeptide-1
Also listed as: GHK-Cu
Read the scope first. Then use the note and questions to examine what the evidence can answer.
- Scoped product status
- Topical cosmetic
- Evidence label
- Cosmetic-use evidence
- Status as of
Reference fields
References for these fields are listed together in Sources.
- Product and use scope
- A skin-care ingredient; this entry is limited to topical cosmetics.
- Route context
- Topical context only; not injection.
- Mechanism
- A complex formed by copper and a tripeptide.
- Evidence
- One post-laser study found no objective between-group skin advantage.
- Limitations
- A topical study cannot establish the effects of an injection.
- Safety
- FDA identifies limited human safety data for injectable GHK-Cu.
A question worth making clear
When a report calls an answer uncertain, ask what remains uncertain rather than treating the word as a single verdict. The concern could be the precision of a number, the interpretation of a comparison, or whether the question matches another setting. Those concerns call for different kinds of clarification. If a report narrows one uncertainty, check whether the others have also been addressed or simply remain outside its scope. Naming the unresolved issue helps a group discuss what further evidence would be useful without asking for more information indiscriminately.
- Does the uncertainty concern the number, its interpretation, or its relevance to another setting?
- Which uncertainty would the proposed additional information actually help us resolve?
- Has one issue become clearer while a different question remains unanswered?
Sources
Each date below belongs to the supplied source record. The references support the entry as a group.
- CIR
CIR · Checked
- Miller
PubMed · Checked
- FDA safety
FDA · Checked
- FDA cosmetics
FDA · Checked